SETD7 and neoplasm: SETD7 exhibits it impact as either an oncogenic protein or a tumor suppressor (Figure 1), thus, SETD7 is emerging as a therapeutic target in YAP-, ER-, AR-, and GLI3-mediated tumorgenesis.